Sun Pharma Advanced Research Company Ltd Quarterly Results

Gross Sales

9.64

27.19

14.91

12.86

16.81

Excise Duty

0

0

0

0

0

Net Sales

9.64

27.19

14.91

12.86

16.81

Other Operating Income

0

0

0

0

0

Other Income

9.14

0

0.19

0.04

1.56

Total Income

18.78

27.19

15.1

12.9

18.37

Total Expenditure

61.72

80.37

88.6

115.77

110.17

PBIDT

-42.94

-53.18

-73.5

-102.87

-91.8

Interest

6.19

4.54

2.8

1.14

0.56

PBDT

-49.13

-57.72

-76.3

-104.01

-92.36

Depreciation

2.68

2.95

3.14

3.16

3.14

Minority Interest Before NP

0

0

0

0

0

Tax

0.06

-0.9

0.07

0.16

0.4

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-51.87

-59.77

-79.51

-107.33

-95.9

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-51.87

-59.77

-79.51

-107.33

-95.9

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-51.87

-59.77

-79.51

-107.33

-95.9

EPS (Unit Curr.)

-1.6

-1.84

-2.45

-3.31

-2.96

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

32.45

32.45

32.45

32.45

32.45

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-445.43

-195.58

-492.95

-799.92

-546.1

PBDTM(%)

-509.64

-212.28

-511.73

-808.78

-549.43

PATM(%)

-538.07

-219.82

-533.26

-834.6

-570.49